Home Cart Sign in  
Chemical Structure| 738606-46-7 Chemical Structure| 738606-46-7

Structure of Bempedoic acid
CAS No.: 738606-46-7

Chemical Structure| 738606-46-7

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

ETC-1002 is an AMPK activator and increase the level of AMPK phosphorylation.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Bempedoic acid

CAS No. :738606-46-7
Formula : C19H36O5
M.W : 344.49
SMILES Code : O=C(O)C(C)(C)CCCCCC(O)CCCCCC(C)(C)C(O)=O
MDL No. :MFCD18800820
InChI Key :HYHMLYSLQUKXKP-UHFFFAOYSA-N
Pubchem ID :10472693

Safety of Bempedoic acid

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of Bempedoic acid

epigenetics
PI3K-AKT

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
Pkd1-null kidney cells (PT-derived) 100 µM 3 days Inhibited cystic growth, reduced cyst area PMC9730828
Pkd1-null kidney cells (IMCD-derived) 100 µM 3 days Inhibited cystic growth, reduced cyst area PMC9730828
AML12 hepatocytes 30 μM 16 hours Fostered lipid accumulation and reduced mitochondrial metabolic activity PMC11488303
RAW-BlueTM cells 25 µM 24 hours Assessed NF-κB/AP-1 activity, showing minimal impact of bempedoic acid on macrophage inflammatory responses. PMC8623589
Primary human hepatocytes 100 μM 18-20 hours To evaluate the effect of ETC-1002 on cholesterol synthesis, results showed that ETC-1002 reduced cholesterol and fatty acid synthesis. PMC5133702
McArdle cells 30 μM 48 hours To study ETC-1002-CoA synthetase activity, results showed that ACSVL1 siRNA treatment reduced ETC-1002-CoA formation. PMC5133702
Bone marrow-derived macrophages (BMMs) 25 µM 24 hours Measured TNF and IL1β secretion and gene expression, finding no significant effect of bempedoic acid on macrophage inflammatory responses. PMC8623589

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT05694260 Hypercholesterolemia PHASE2 RECRUITING 2024-05-24 Smidt Heart Institute at Cedar... More >>s-Sinai, Los Angeles, California, 90048, United States|Continental Clinical Solutions, Towson, Maryland, 21204, United States|Washington University School of Medicine, Division of Endocrinology, Metabolism and Lipid Research., Saint Louis, Missouri, 63110, United States|Wake Forest University Health Sciences, Winston-Salem, North Carolina, 27157, United States|Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, 45229, United States|University of Utah and Primary Children's Hospital, Salt Lake City, Utah, 84113, United States|University of Alberta Hospital - Stollery Children's Hospital, Edmonton, Alberta, T6G 2B7, Canada|McMaster University Medical Center, Hamilton, Ontario, L8N 3Z5, Canada|The Hospital for Sick Children (SickKids), Toronto, Ontario, M5G 1X8, Canada|Ecogene-21, Chicoutimi, Quebec, G7H 5H6, Canada|Rigshospitalet, Copenhagen, 2100, Denmark|Kinder- und Jugendkrankenhaus AUF DER BULT, Hannover, Germany|Amsterdam UMC - Locatie AMC, Amsterdam, 1105 AZ, Netherlands|Erasmus MC, Rotterdam, 3015 G, Netherlands|Corporacio Sanitaria Parc Tauli - Hospital de Sabadell, Barcelona, 8208, Spain|Hospital Sant Joan de Deu, Barcelona, 8950, Spain|Hospital Universitario de Jerez de la Frontera, Cadiz, 11407, Spain|Hospital Universitario Reina Sofia, Córdoba, 14004, Spain|Hospital Abente y Lago, La Coru?a, 15001, Spain|Hospital Universitario Ramon y Cajal, Madrid, 28034, Spain Less <<
NCT06035874 Type 2 Diabetes|Non Alcholic F... More >>atty Liver Disease Less << RECRUITING 2025-02-01 Division Of Endocrinology , Me... More >>danta The Medicity Sec 38, Gurgaon, Haryana, 122001, India Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.90mL

0.58mL

0.29mL

14.51mL

2.90mL

1.45mL

29.03mL

5.81mL

2.90mL

References

 

Historical Records

Categories